Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people on semaglutide find their appetite drops so sharply that they struggle to eat more than 800 calories a day, at least in the early weeks of treatment. That is a real experience, not an exaggeration, and it raises a fair question: is eating that little safe while taking this medicine? The short answer is that a very-low-calorie intake can be appropriate in specific clinical circumstances, but on a long-term basis it carries real risks, particularly muscle loss and nutritional deficiency. Semaglutide is a prescription-only medicine; how to eat alongside it is something a prescriber and, ideally, a dietitian should guide for your situation specifically. The sections below set out what the evidence and NHS guidance actually say, step by step.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide activates the GLP-1 receptor in the gut and brain. It slows how quickly the stomach empties, extends the feeling of fullness, and reduces hunger signals. During the starter and early titration phases, those effects can feel dramatic. Many people find that foods they previously enjoyed hold no appeal, and portions that once seemed modest now feel enormous.
The result, for some, is an unplanned very-low-calorie day. Eight hundred calories is not a target set by any clinical protocol for GLP-1 treatment; it simply describes what some people naturally land at when appetite is strongly suppressed. The NHS medicines page for semaglutide confirms appetite reduction as an expected pharmacological effect, not a cause for alarm in itself, though the consequences of sustaining a very low intake matter a great deal.
Understanding that distinction, between an incidental low day and a sustained pattern, is the practical starting point. If you want a clearer picture of how calorie intake typically works on Wegovy, that background is worth reading before drawing conclusions from a single low day. The guidance diverges depending on which situation you are in, and what Wegovy treatment involves overall is worth reading alongside this.
A brief period of very restricted eating is physiologically different from months of it. The concern with a prolonged very-low-calorie intake, broadly defined as under 800 calories per day, is primarily about body composition. When calorie supply falls sharply and protein is inadequate, the body draws on muscle tissue as well as fat for energy. Losing muscle reduces your resting metabolic rate, which makes it harder to maintain weight after treatment and increases the risk of what clinicians sometimes call metabolic adaptation.
Micronutrient deficiencies are a second concern. Eight hundred calories of mixed food leaves little room for the range of vitamins and minerals a healthy body needs. Fatigue, hair thinning, poor wound healing and low mood can all follow a prolonged deficit, and they are sometimes misattributed to the medicine rather than to the diet.
This is why NHS England's guidance on weight-management injections consistently pairs the medicine with structured dietary support rather than simply letting appetite suppression drive intake to whatever level it reaches. You can explore what to eat on Wegovy for practical guidance on food choices that help you protect protein and nutrients even when overall volume is low. A useful broader reference is the NHS England guidance on weight-management injections, which sets out the wraparound care principles for semaglutide treatment.
If you find yourself at 800 calories or fewer most days, a few practical adjustments can raise intake without forcing food. The first is protein at every eating occasion, however small. Eggs, Greek yoghurt, fish, legumes and lean meat carry the most nutritional weight per calorie. The second is liquid calories where solid food feels unappealing: a small glass of full-fat milk, a protein shake or a fortified smoothie can close a gap without requiring volume eating.
Timing matters too. Some people on semaglutide find a small breakfast easier than a large one, so front-loading the day rather than relying on an evening meal that never arrives works better for their pattern. Practically, keeping something like a portion of yoghurt in the fridge door as a reliable morning option, within reach before anything else, can be enough to anchor the first meal of the day. This kind of small structural habit is easier to sustain than a detailed meal plan during weeks when appetite is unreliable.
For a fuller look at how total energy intake tends to shift during treatment, our page on how many calories people tend to eat per day on Wegovy provides useful context, and how many calories to aim for on Wegovy explores the question from a planning angle. The evidence on calorie levels during Wegovy treatment is also worth reviewing if you want a grounded picture of what the clinical data shows.
Not every low-appetite day warrants a call, but some patterns do. If you are consistently below a reasonable daily intake for more than two or three weeks, feeling faint, losing hair in noticeable amounts, or finding that fatigue is affecting daily life, those are signals to raise with your prescriber or a dietitian. Dose timing or the pace of titration can sometimes be adjusted; in some cases, a temporary pause at a lower dose is appropriate. That is a clinical judgement, not one to make alone based on a forum post.
The STEP 1 trial, published in the New England Journal of Medicine, demonstrated around 15% average body-weight reduction over 68 weeks in adults taking semaglutide 2.4mg alongside lifestyle support. That result came with dietary and activity guidance running alongside the medicine, not from leaving participants to eat whatever their suppressed appetite dictated. The difference matters: structured support, including attention to calorie floors as well as ceilings, was part of the clinical design.
If questions about whether Wegovy is right for you are still open, our prescribers are available for a free consultation and can discuss your dietary history alongside clinical suitability. You can also find an overview of treatment options at our weight-loss treatments page. For anything specific to your own situation, our aftercare team is available seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.